Urolog. pro Praxi, 2011; 12(1): 29-32

Incontinence and menopause

MUDr.Zuzana Trněná1,2, MUDr.Lukáš Horčička2
1 Univerzita Karlova v Praze, 3. lékařská fakulta a FN Královské Vinohrady, Urologická klinika, Praha
2 GONA spol. s r. o. –, nestátní zdravotnické zařízení, Praha

The present review deals with urinary incontinence in climacteric women. Urinary incontinence, an involuntary/uncontrolled leakage

of urine, affects up to fifty percent of women at some point in their lives. The groups with the highest risk are peri- and postmenopausal

women. The gradual loss of ovarian function results in decreased oestrogen levels. Oestrogen deficiency causes the tissues of the uropoietic

system to atrophy with all its implications, including the development or impairment of urinary incontinence. Oestrogen hormone

replacement therapy has been shown to have a positive impact on increasing the quality of life of patients as well as improving their

complaints, whether in monotherapy or in combination with other treatment options for incontinence.

Keywords: incontinence, menopause, oestrogens, urogenital atrophy, parasympatholytics, tension-free tape

Published: February 25, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Trněná Z, Horčička L. Incontinence and menopause. Urol. praxi. 2011;12(1):29-32.
Download citation

References

  1. Abrams P, et al. Clinical Manual of Incontinence in Women. Health Publications 2005.
  2. Živný J, Fait T. Endokrinologie klimakteria a hormonální substituční terapie. Psychiatr. pro Praxi 2003; 3: 101-106.
  3. Robinson D, Cardozo L. The role of estrogens in female lower urinary tract dysfunction. Urology 2003; 62: 45-51. Go to original source... Go to PubMed...
  4. Calleja-Agius J, Brincat M. Urogenital atrophy. Climacteric 2009; 12(4): 279-285. Go to original source... Go to PubMed...
  5. Hejlová P, Zmrhal J. Vliv estrogenu na dolní cesty močové. Prakt Gyn 2002; 4: 26-28.
  6. Cardozo L. Role of estrogens in the treatment of female urinary incontinence. JAGS 1990; 38: 326-328. Go to original source... Go to PubMed...
  7. Simunic V, et al. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obset 2003; 82: 187-197. Go to original source... Go to PubMed...
  8. Gärtner M. Hormonální terapie a léčba inkontinence moči. Prakt Gyn 2006; 10(4): 147-148.
  9. Kolařík D. Konzervativní léčba v urogynekologii. In: Halaška, et al. Urogynekologie. Galén 2004: 75-87.
  10. Krhut J. Farmakologická léčba stresové inkontinence. Urolog. pro Praxi 2006; 2: 52-54.
  11. Nygaard I, et al. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed incontinence. Am J Obstet Gynecol 1996; 174: 120-125. Go to original source... Go to PubMed...
  12. Dzvinčuk P, Müller O, Látalová E. Inkontinence moči z pohledu gynekologa. Interní Med. 2008; 10(2): 90-91.
  13. Kolařík D, Martan A. Farmakologická léčba v urogynekologii. In: Halaška, et al. Urogynekologie. Galén, 2004: 95-107.
  14. Cardozo L, Lose G, McClish D, Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 2004; 83: 892-897. Go to original source... Go to PubMed...
  15. Fantl JA, Cardozo L, McClish D. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Comittee. Obstet Gynecol 1994; 83: 12-18. Go to PubMed...
  16. Miklica J. Nemoci ženského močového traktu z pohledu urogynekologa. Med. pro Praxi 2006; 3: 132-134.
  17. Ulmsten U, et al. A multicenter study of tension free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J 1998; 9: 210-213. Go to original source... Go to PubMed...
  18. Drutz H, et al. Surgical management of pelvic organ prolapse and stress urinary incontinence. Clin Obstet Gynecol 1998; 41: 786-793. Go to original source... Go to PubMed...
  19. Kolařík D, Šimon V, Otčenášek M, Martan A, Halaška M, Mašata J. Léčba stresové inkontinence moči u žen pomocí periuretrálních implantátů. Česká gynekologie 2000; 2: 82-88.
  20. Horčička L. Pesary v urogynekologii. Prakt Gyn 2002; 5: 6-7.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.